Skip to main content

Unable to load price data. Sorry.


ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA.DL)

CAPS Rating: No stars

An ophthalmic pharmaceutical company, focused on the development and commercialization of products for serious diseases and conditions of the eye.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:ISTA.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

eyedocarun (< 20)
Submitted July 12, 2007

I'm an eye doc so I have a little insight into the core products offered by ISTA. Their beta-blocker Istalol is just an okay product, but I'm very optimistic about the future of their other product Xibrom, which is a non-steroidal anti-inflammatory… More

zzlangerhans (99.14)
Submitted February 15, 2012

ISTA has surprisingly maintained the dramatic elevation in share price that came about due to Valeant's takeout bid, despite the fact that Valeant has moved on from the stalled negotiations and purchased Eyetech instead. The share price is nearly… More


  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about ISTA.DL.

No one has written a Pitch for ISTA.DL stock yet. Tell us why you think ISTA.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in ISTA.DL.

No players have picked ISTA.DL yet. Tell us why you think ISTA.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ISTA.DL.